References
- Royce TJ, Sanoff HK, Rewari A. Telemedicine for cancer care in the time of COVID-19. JAMA Oncol. 2020;6(11):1698. doi:https://doi.org/10.1001/jamaoncol.2020.2684.
- Tsuji Y, Miyajima N, Kuroiwa G, Kato M, Nobuoka A, Ohi M, et al. Outpatient chemotherapy with infusional 5-fluorouracil in advanced gastrointestinal cancer. Gan to Kagaku Ryoho. 1999;26(Suppl 2):346–350.
- Corsi MP, Shea K, W Knoebel R. Impact of transitioning inpatient chemotherapy regimens to the outpatient setting. J Oncol Pharm Pract. 2020;26(6):1324–1330. doi:https://doi.org/10.1177/1078155219891566.
- Melosky B, Wheatley-Price P, Juergens RA, Sacher A, Leighl NB, Tsao M-S, et al. The rapidly evolving landscape of novel targeted therapies in advanced non-small cell lung cancer. Lung Cancer. 2021;160:136–51. doi:https://doi.org/10.1016/j.lungcan.2021.06.002.
- Ellis M. Febrile neutropenia. Ann N Y Acad Sci. 2008;1138:329–350. doi:https://doi.org/10.1196/annals.1414.035.
- Haykal T, Zayed Y, Deliwala S, Kerbage J, Ponnapalli A, Malladi S, et al. Direct oral anticoagulant versus low-molecular-weight heparin for treatment of venous thromboembolism in cancer patients: An updated meta-analysis of randomized controlled trials. Thromb Res. 2020;194:57–65. doi:https://doi.org/10.1016/j.thromres.2020.06.025.
- Zierhut HA, MacFarlane IM, Ahmed Z, Davies J. Genetic counselors' experiences and interest in telegenetics and remote counseling. J Genet Couns. 2018;27(2):329–38. doi:https://doi.org/10.1007/s10897-017-0200-x.
- Hasson SP, Waissengrin B, Shachar E, Hodruj M, Fayngor R, Brezis M, et al. Rapid implementation of telemedicine during the COVID-19 pandemic: perspectives and preferences of patients with cancer. Oncologist. 2021;26(4):e679–e685. doi: https://doi.org/10.1002/onco.13676.
- Sung AD, Nichols KR, Chao NJ. House calls for stem cell transplant patients during the COVID-19 pandemic. Blood. 2020;136(3):370–371. doi:https://doi.org/10.1182/blood.2020006573.
- Peled JU, Gomes ALC, Devlin SM, Littmann ER, Taur Y, Sung AD, et al. Microbiota as predictor of mortality in allogeneic hematopoietic-cell transplantation. N Engl J Med. 2020;382(9):822–834. doi:https://doi.org/10.1056/NEJMoa1900623.
- Murthy V, Wilson J, Suhr J, James L, Tombs H, Shereef E, et al. Moving cancer care closer to home: a single-centre experience of home chemotherapy administration for patients with myelodysplastic syndrome. ESMO Open. 2019;4(2):e000434. doi:https://doi.org/10.1136/esmoopen-2018-000434.